DSGN
Design Therapeutics Inc
12.10$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.01 | -0.32 | -0.64 | -0.92 | -1.05 | -0.76 | -0.95 | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 0.00 | 0.02 | 0.10 | 0.20 | 0.23 | 0.23 | 0.25 | |
| 0.00 | 0.02 | 0.10 | 0.20 | – | – | – | |
| 0.07 | -0.03 | 0.03 | 0.04 | 0.01 | -0.02 | 0.05 | |
| 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | 0.01 | 0.00 | |
| -1.23 | -1.23 | -1.17 | -3.97 | 0.94 | 0.78 | 0.40 | |
| – | – | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 0.01 | -0.01 | 0.00 | -0.01 | – | – | – | |
| 0.01 | 1.64 | 8.25 | 0.00 | 0.01 | 0.01 | 0.45 | |
| 0.00 | 0.08 | 6.45 | -4.88 | -0.09 | 0.02 | -0.10 | |
| -0.01 | -0.32 | -0.67 | -0.94 | -1.05 | -0.77 | -0.95 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.